Expression of the Human Telomerase Reverse Transcriptase in Pheochromocytoma and Neuroblastoma Tissues

Endocrine Journal

Volumn 51, Issue 1, 2004, Pages 47-52

  Isobe, Kazumasa ^a   Yashiro, Toru ^a   Omura, Sakie ^a   Kaneko, Michio ^a   Kaneko, Setsuko ^a   Kamma, Hiroshi ^a   Tatsuno, Ichiro ^b   Takekoshi, Kazuhiro ^a   Kawakami, Yasushi ^a   Nakai, Toshiaki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

hTERT; Malignancy; mRNA; Neuroblastoma; Pheochromocytoma

Indexed keywords

MESSENGER RNA; RIBONUCLEOPROTEIN; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHEOCHROMOCYTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADRENAL GLAND NEOPLASMS; ADULT; AGED; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEUROBLASTOMA; PHEOCHROMOCYTOMA; RNA, MESSENGER; TELOMERASE;

EID: 12144287566     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.51.47     Document Type: Article

References (18)

1. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu QY, Bacchetti S, Haber DA, Weinberg RA (1997) HEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90: 785-795.
2. Nakamura TM, Morin GB, Chapman KB (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277: 955-959.
3. Kim NW (1997) Clinical implications of telomerase in cancer. Eur J Cancer 33: 781-786.
4. Shay JW, Bacchetti S (1997) A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791.
5. Falchetti ML, Pallini R, Larocca LM, Verna R, D'Ambrosio E (1999) Telomerase expression in intracranial tumors: prognostic potential for malignant gliomas and meningomas. J Clin Pathol 52: 234-236.
6. Langford LA, Piatyszek MA, Xu R, Schold SC, Wright WE, Shay JW (1997) Telomerase activity in ordinary meningiomas predicts poor outcome. Hum Pathol 28: 416-420.
7. Ducrest AL, Szutorisz H, Lingner J, Nabholz M (2002) Regulation of the human telomerae reverse transcriptase gene. Oncogene 21: 541-552.
8. Gupta D, Shidham V, Holden J, Layfield L (2000) Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas. Appl Immunohistochem Mol Morphol 8: 267-274.
9. Kinoshita H, Ogawa O, Mishina M, Oka H, Okumura K, Yamabe H, Terachi T, Yoshida O (1998) Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features. Urol Res 26: 29-32.
10. Kubota Y, Nakada T, Sasagawa I, Yanai H, Itoh K (1998) Elevated levels of telomerase activity in malignant pheochromocytoma. Cancer 82: 176-179.
11. Bamberger CM, Else T, Bamberger AM, Frilling A, Beil FU, Allolio B, Schulte HM (1999) Telomerase activity in benign and malignant adrenal tumors. Exp Clin Endocrinol Diabetes 107: 272-275.
12. Hiyama E, Hiyama K (2002) Clinical utility of telomerase in cancer. Oncogene 21: 6643-649.
13. Linnolia RI, Keiser HR, Steinberg SM, Lack EE (1990) Histopathology of benign versus malignant sympatho-adrenal paragangliomas: clinicopathologic study of 120 cases including unusual histopathologic features. Hum Pathol 21: 1168-1180.
14. Hiyama E, Hiyama K, Ohtsu K, Yamaoka H, Ichikawa T, Shay JW, Yokoyama T (1997) Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour? Eur J Cancer 33: 1932-1936.
15. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M (1995) Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 155: 3711-3715.
16. Ohji H, Sasagawa I, Ichiyanagi O, Suzuki Y, Nakada T (2001) Tumor angiogenesis and Ki-67 expression in phaeochromocytoma. BJU Int 87: 381-385.
17. Elder EE, Xu D, Hoog A, Enberg U, Pisa P, Gruber A, Larsson C, Backdahl M (2003) Ki-67 and hTERT expression can aid in the distinction between malignant and benign pheochromocytoma and paraganglioma. Mod Pathol 16: 246-255.
18. Krams M, Claviez A, Heidorn K, Krupp G, Parwaresch R, Harmsd D, Rudolph P (2001) Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas. Am J Pathol 159: 1925-1932.